WF Woori posts 55 Q4 2025 EPS miss against analyst forecasts sending shares down nearly 5 today Eli Lilly and Company LLY GLP1 Oral Market Competition Intensifies As Early Uptake Data Benchmarks Novo Nordisks Oral Wegovy Lead BioLife BLFS Stock Technical Risk Signals Q4 2025 Profit Exceeds Views